A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Immunity

• Publication date

  2001-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1074-7613(01)00232-1PMID 11728344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The TNF and TNF Receptor Review Superfamilies: Integrating Mammalian Biology

  2001cited by this paper
• Involvement of Tweak in Interferon γ–Stimulated Monocyte Cytotoxicity

  2000cited by this paper
• Down-regulated expression of TWEAK mRNA in acute and chronic inflammatory pathologies.

  2000cited by this paper
• The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas.

  2000cited by this paper
• Studies on the interaction between TWEAK and the death receptor WSL‐1/TRAMP (DR3)

  2000cited by this paper
• TWEAK stimulation of astrocytes and the proinflammatory consequences

  2000cited by this paper
• TWEAK Induces Angiogenesis and Proliferation of Endothelial Cells*

  1999cited by this paper
• The Mitogen-inducible Fn14 Gene Encodes a Type I Transmembrane Protein that Modulates Fibroblast Adhesion and Migration*

  1999cited by this paper
• TWEAK can induce cell death via endogenous TNF and TNF receptor 1

  1999cited by this paper
• Vascular smooth muscle cells express the transcriptional corepressor NAB2 in response to injury.

  1999cited by this paper
• Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.

  1999cited by this paper
• Identification of a ligand for the death-domain-containing receptor Apo3.

  1998cited by this paper
• The Involvement of Multiple Tumor Necrosis Factor Receptor (TNFR)-associated Factors in the Signaling Mechanisms of Receptor Activator of NF-κB, a Member of the TNFR Superfamily*

  1998cited by this paper
• The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily.

  1998cited by this paper
• Identification of a subpopulation of human renal microvascular endothelial cells with capacity to form capillary-like cord and tube structures

  1997cited by this paper
• TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis*

  1997cited by this paper
• Development of Inflammatory Angiogenesis by Local Stimulation of Fas In Vivo

  1997cited by this paper
• A model of angiogenesis in the mouse cornea.

  1996cited by this paper
• Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha.

  1996cited by this paper
• Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis.

  1995cited by this paper
• Identification and characterization of a new member of the TNF family that induces apoptosis.

  1995cited by this paper
• Structural characteristics of CD40 ligand that determine biological function.

  1994cited by this paper
• CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF.

  1993cited by this paper
• Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor.

  1993cited by this paper
• Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells.

  1992cited by this paper

• Integrated experimental and computational approaches to analyze TNF superfamily ligand-receptor interactions.

  2026cites this paper
• The TWEAK/FN14 Axis Influences the Phenotype of Cardiac Fibroblasts during Pathological Cardiac Remodeling through the Regulation of EGR1.

  2026cites this paper
• Fibroblast growth factor-inducible 14 signalling pathway in cutaneous wounds: a potential therapeutic target.

  2026cites this paper
• Potential role of TNFRSF12A in linking glioblastoma and alzheimer’s disease via shared tumour suppressor pathways

  2025cites this paper
• Blood Progenitor Cell Mobilization Driven by TWEAK Promotes Neovascularization and Reduces Brain Damage in a Rat Model of Intracerebral Hemorrhage

  2025cites this paper
• Mechanistic Insights into Maltol-Mediated Reversal of Postmenopausal Osteoporosis via Regulation of CDK14 Ubiquitination in Macrophages.

  2025cites this paper
• Tumor Necrosis Factor Receptor Superfamily Member 12A Enhances Retinal Ganglion Cell Survival and Promotes Axon Regeneration

  2025cites this paper
• Circulating inflammatory proteins associated with risks of schizophrenia, bipolar disorder, and major depressive disorder: a mendelian randomization study

  2025cites this paper
• Bioinformatic identification of important roles of COL1A1 and TNFRSF12A in cartilage injury and osteoporosis

  2025cites this paper
• Correlation of the fibroblast growth factor‐inducible 14 receptor and progranulin as prognostic biological markers in ductal invasive breast cancer: Immunohistochemical study

  2025cites this paper
• Combined Plasma Olink Proteomics and Transcriptomics Identifies CXCL1 and TNFRSF12A as Potential Predictive and Diagnostic Inflammatory Markers for Acute Kidney Injury

  2024cites this paper
• Proposed Hypothesis of TWEAK/Fn14 Receptor Modulation in Autism Spectrum Disorder.

  2024cites this paper
• Molecular Changes Implicate Angiogenesis and Arterial Remodeling in Systemic Sclerosis–Associated and Idiopathic Pulmonary Hypertension

  2024cites this paper
• TWEAK/Fn14 disrupts Th17/Treg balance and aggravates conjunctivitis by inhibiting the Nrf2/HO-1 pathway in allergic conjunctivitis mice

  2024cites this paper
• Role of TNFRSF12A in cell proliferation, apoptosis, and proinflammatory cytokine expression by regulating the MAPK and NF-κB pathways in thyroid cancer cells.

  2024cites this paper
• The Role of Clycodelin in Conversion of CD11b+ Cells to MDSCs and Regulation of Their Functional Activity

  2024cites this paper
• Integrated analysis of spatial transcriptomics and CT phenotypes for unveiling the novel molecular characteristics of recurrent and non-recurrent high-grade serous ovarian cancer

  2024cites this paper
• Inflammation-related Proteins Support Diagnosis of Inflammatory Bowel Disease and Are Modified by Exclusive Enteral Nutrition in Children With Crohn’s Disease, Especially of Ileal Phenotype

  2024cites this paper
• TRAFfic signals: High-throughput CAR discovery in NK cells reveals novel TRAF-binding endodomains that drive enhanced persistence and cytotoxicity

  2023cites this paper
• TWEAK/FN14 promotes profibrogenic pathway activation in Prominin-1-expressing hepatic progenitor cells in biliary atresia

  2023cites this paper
• Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity

  2023cites this paper
• Copper-containing titanium alloys promote the coupling of osteogenesis and angiogenesis by releasing copper ions.

  2023cites this paper
• Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1

  2023influential citation
• Fn14 promotes myoblast fusion during regenerative myogenesis

  2023cites this paper
• The Roles of Long-Term Hyperhomocysteinemia and Micronutrient Supplementation in the AppNL–G–F Model of Alzheimer’s Disease

  2022cites this paper
• Exercise reprograms the inflammatory landscape of multiple stem cell compartments during mammalian aging

  2022cites this paper
• A potential fate decision landscape of the TWEAK/Fn14 axis on stem and progenitor cells: a systematic review

  2022cites this paper
• TNF Receptor Associated Factor 2 (TRAF2) Signaling in Cancer

  2022cites this paper
• Comprehensive Molecular Analyses of a TNF Family-Based Gene Signature as a Potentially Novel Prognostic Biomarker for Cervical Cancer

  2022cites this paper
• Targeted ablation of Fn14 receptor improves exercise capacity and inhibits neurogenic muscle atrophy

  2022cites this paper
• Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis

  2022cites this paper
• A Novel Multi-Omics Analysis Model for Diagnosis and Survival Prediction of Lower-Grade Glioma Patients

  2022cites this paper
• Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy

  2022cites this paper
• TWEAK-Fn14 Axis Induces Calcium-Associated Autophagy and Cell Death To Control Mycobacterial Survival in Macrophages

  2022cites this paper
• Status of TWEAK DNA methylation and mRNA expression in systemic lupus erythematosus

  2022cites this paper
• Genome assembly of the tayra (Eira barbara, Mustelidae) and comparative genomic analysis reveal adaptive genetic variation in the subfamily Guloninae

  2021cites this paper
• ThPOK transcriptionally inactivates TNFRSF12A to increase the proliferation of T cells with the involvement of the NF-kB pathway.

  2021cites this paper
• Distal Lung Microenvironment Triggers Release of Mediators Recognized as Potential Systemic Biomarkers for Idiopathic Pulmonary Fibrosis

  2021influential citation
• Evaluation of Computationally Designed Peptides against TWEAK, a Cytokine of the Tumour Necrosis Factor Ligand Family

  2021cites this paper
• TWEAK–Fn14 as a common pathway in the heart and the kidneys in cardiorenal syndrome

  2021cites this paper
• A Novel Immune-Related Prognostic Biomarker and Target Associated With Malignant Progression of Glioma

  2021cites this paper
• Activation of fibroblast growth factor-inducible 14 in the early phase of childhood IgA nephropathy

  2021cites this paper
• Changes in serum TNF‐like weak inducer of apoptosis (TWEAK) levels and Psoriasis Area Severity Index (PASI) scores in plaque psoriasis patients treated with conventional versus anti‐TNF treatments

  2020cites this paper
• RNA-protein correlation of liver toxicity markers in HepaRG cells

  2020cites this paper
• Identification of gene expression markers and development of evaluation method using cell-based and RT-PCR-based assay for skin sensitising potential of chemicals

  2020cites this paper
• Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3

  2020cites this paper
• Controversies in TWEAK-Fn14 signaling in skeletal muscle atrophy and regeneration

  2020cites this paper
• Mining the proliferative diabetic retinopathy-associated genes and pathways by integrated bioinformatic analysis

  2020cites this paper
• TWEAK/Fn14 axis in respiratory diseases.

  2020cites this paper
• Emerging molecular mediators and targets for age-related skeletal muscle atrophy.

  2020cites this paper
• Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges

  2020influential citation
• The mechanism of Chinese herbal formula HQT in the treatment of rheumatoid arthritis is related to its regulation of lncRNA uc.477 and miR‐19b

  2020cites this paper
• The TNF-like weak inducer of the apoptosis/fibroblast growth factor-inducible molecule 14 axis mediates histamine and platelet-activating factor-induced subcutaneous vascular leakage and anaphylactic shock.

  2020cites this paper
• Diagnostic value of TWEAK for predicting active lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis

  2020influential citation
• Decreased expression of TNFRSF12A in thyroid gland cancer predicts poor prognosis

  2020cites this paper
• Immunohistochemical expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible immediate early response protein 14 in oral squamous cell carcinoma and its implications.

  2019cites this paper
• Longitudinal single cell transcriptomics reveals Krt8+ alveolar epithelial progenitors in lung regeneration

  2019cites this paper
• A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis

  2019cites this paper
• Serum soluble TWEAK levels in non-alcoholic fatty liver disease

  2019cites this paper
• Ginkgo Flavonol Glycosides or Ginkgolides Tend to Differentially Protect Myocardial or Cerebral Ischemia–Reperfusion Injury via Regulation of TWEAK-Fn14 Signaling in Heart and Brain

  2019cites this paper
• Exploring the roles of atypical MAP kinases ERK3 and ERK4 during inflammation

  2019cites this paper
• Temporal Splicing Switches in Elements of the TNF-Pathway Identified by Computational Analysis of Transcriptome Data for Human Cell Lines

  2019cites this paper
• Interferon-Gamma and Tumor Necrosis Factor-Related Weak Inducer of Apoptosis Expression in Neoangiogenesis in Colorectal Polypoid Lesions

  2019cites this paper
• Genome-Wide Microarray Analysis Suggests Transcriptomic Response May Not Play a Major Role in High- to Low-Altitude Acclimation in Harvest Mouse (Micromys minutus)

  2019cites this paper
• Enhanced TGF-β Signaling Contributes to the Insulin-Induced Angiogenic Responses of Endothelial Cells

  2019cites this paper
• Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis: a prospective multicentre study

  2019cites this paper
• How much apoptosis does carbon monoxide poisoning cause? Primary clinical soluble TWEAK protein level study

  2019cites this paper
• The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond.

  2019cites this paper
• Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma

  2019cites this paper
• NETO2 promotes invasion and metastasis of gastric cancer cells via activation of PI3K/Akt/NF-κB/Snail axis and predicts outcome of the patients

  2019cites this paper
• Serum sTWEAK levels in chronic periodontitis and type 2 diabetes mellitus.

  2019cites this paper
• Comparison of liver gene expression by RNAseq and PCR analysis after 8 weeks of feeding soy protein isolate- or casein-based diets in an obese liver steatosis rat model.

  2019cites this paper
• Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.

  2019cites this paper
• TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?

  2019cites this paper
• Effect of remote ischemic preconditioning on hepatic ischemia-reperfusion injury in patients undergoing liver resection: a randomized controlled trial.

  2019cites this paper
• Primary liver cancer is the second leading cause of cancer-related mortality in men globally and the sixth leading cause of cancer-related mortality in women (1). according to the statistics from the international agency for research

  2019cites this paper
• TNFS12: TWEAK Deficiency

  2019cites this paper
• Effect of influenza vaccine on tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in older adults.

  2018cites this paper
• Tumor necrosis factor-like weak inducer of apoptosis induces inflammation in Graves’ orbital fibroblasts

  2018cites this paper
• Anti-mitotic chemotherapeutics promote apoptosis through TL1A-activated death receptor 3 in cancer cells

  2018cites this paper
• Overexpression of Fn14 in gliomas: tumor progression and poor prognosis.

  2018cites this paper
• High TNFRSF12A level associated with MMP-9 overexpression is linked to poor prognosis in breast cancer: Gene set enrichment analysis and validation in large-scale cohorts

  2018cites this paper
• The C‐terminal region of tumor necrosis factor like weak inducer of apoptosis is required for interaction with advanced glycation end products

  2018cites this paper
• Biomeasures and mechanistic modeling highlight PK/PD risks for a monoclonal antibody targeting Fn14 in kidney disease

  2018cites this paper
• Investigating the mechanism of bone marrow failure observed in patients with acute myeloid leukaemia

  2018cites this paper
• TWEAK Deficiency

  2018cites this paper
• Targeting of Fn14 prevents cachexia

  2018influential citation
• Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells

  2017cites this paper
• Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases

  2017cites this paper
• Activación del eje TWEAK/FN14 durante el remodelado vascular : mecanismos moleculares y modulación terapéutica

  2017influential citation
• Tweak up-regulates endothelin-1 system in mouse and human endothelial cells

  2017cites this paper
• Modeling Hepatocellular Toxicity of Enavatuzumab, a Humanized Anti-TweakR Antibody

  2017cites this paper
• Bioinformatic prediction and experimental validation of a PE38-based recombinant immunotoxin targeting the Fn14 receptor in cancer cells.

  2017cites this paper
• The role of tumor necrosis factor-like weak inducer of apoptosis in atherosclerosis via its two different receptors ( Review )

  2017cites this paper
• Connective Tissue Growth Factor Promotes Efficient Generation of Human Induced Pluripotent Stem Cell‐Derived Choroidal Endothelium

  2017cites this paper
• Posttranslational Modifications and Death Receptor Signalling

  2017cites this paper
• Inhibition of the TWEAK/Fn14 pathway attenuates autoimmune arthritis in a SKG mouse model.

  2017cites this paper
• Cell Death in the Developing Brain after Hypoxia-Ischemia

  2017cites this paper
• Phase I Study of Enavatuzumab, a First-in-Class Humanized Monoclonal Antibody Targeting the TWEAK Receptor, in Patients with Advanced Solid Tumors

  2017influential citation
• Advanced glycation end products attenuate the function of tumor necrosis factor-like weak inducer of apoptosis to regulate the inflammatory response

  2017cites this paper